The U.S. Centers for Disease Control and Prevention has ended its emergency response to the H5N1 bird flu outbreak, a move ...

For decades, one of the world’s most contagious diseases was considered eradicated in the U.S. But now measles is roaring back.

NPR's Pien Huang speaks with pediatrician Alexandra Cvijanovich and Professor Jason L. Schwartz about trying to shore up trust about vaccines.

Professor Hirohide Saito and his research team have developed a new microRNA-responsive hybrid mRNA switch, enabling precise, ...

Eli Lilly (NYSE: LLY) led the way in pharma M&A during June. The US pharma major announced two major deals in the month, both ...

When the COVID-19 pandemic swept across the world in 2020, the mRNA vaccines came to the rescue of many people—but in the ...

The elephant vaccine closely resembles other mRNA vaccines made for humans. mRNA packed in lipid nanoparticles carries ...

Many Indian firms chase quick returns, rely on imported technology, and underinvest in research. But innovation needs ...

The new results helped boost Moderna’s stock by more than 4% in early trading June 30, though the company’s shares are still down about 32% for the year. Moderna has more on the science behind mRNA.

Health Minister says all corporate and private companies will be directed to mandatorily provide annual health screening for ...